These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7603511)
1. Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mita S; Tokunaga M; Kumamoto T; Uchino M; Nonaka I; Ando M Muscle Nerve Suppl; 1995; 3():S113-8. PubMed ID: 7603511 [TBL] [Abstract][Full Text] [Related]
2. Single muscle fiber analysis of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Tokunaga M; Mita S; Murakami T; Kumamoto T; Uchino M; Nonaka I; Ando M Ann Neurol; 1994 Apr; 35(4):413-9. PubMed ID: 8154867 [TBL] [Abstract][Full Text] [Related]
3. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Tokunaga M; Mita S; Sakuta R; Nonaka I; Araki S Ann Neurol; 1993 Mar; 33(3):275-80. PubMed ID: 7684581 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of MELAS and mitochondrial DNA mutations. Goto Y Muscle Nerve Suppl; 1995; 3():S107-12. PubMed ID: 7603510 [TBL] [Abstract][Full Text] [Related]
5. Single muscle fiber analysis of myoclonus epilepsy with ragged-red fibers. Mita S; Tokunaga M; Uyama E; Kumamoto T; Uekawa K; Uchino M Muscle Nerve; 1998 Apr; 21(4):490-7. PubMed ID: 9533783 [TBL] [Abstract][Full Text] [Related]
6. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. Melone MA; Tessa A; Petrini S; Lus G; Sampaolo S; di Fede G; Santorelli FM; Cotrufo R Arch Neurol; 2004 Feb; 61(2):269-72. PubMed ID: 14967777 [TBL] [Abstract][Full Text] [Related]
7. The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Moraes CT; Ricci E; Bonilla E; DiMauro S; Schon EA Am J Hum Genet; 1992 May; 50(5):934-49. PubMed ID: 1315123 [TBL] [Abstract][Full Text] [Related]
8. A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies. Hammans SR; Sweeney MG; Wicks DA; Morgan-Hughes JA; Harding AE Brain; 1992 Apr; 115 ( Pt 2)():343-65. PubMed ID: 1606473 [TBL] [Abstract][Full Text] [Related]
9. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA. Campos Y; Martin MA; Lorenzo G; Aparicio M; Cabello A; Arenas J Muscle Nerve; 1996 Feb; 19(2):187-90. PubMed ID: 8559168 [TBL] [Abstract][Full Text] [Related]
10. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Naini AB; Lu J; Kaufmann P; Bernstein RA; Mancuso M; Bonilla E; Hirano M; DiMauro S Arch Neurol; 2005 Mar; 62(3):473-6. PubMed ID: 15767514 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome c oxidase activity is deficient in blood vessels of patients with myoclonus epilepsy with ragged-red fibers. Hasegawa H; Matsuoka T; Goto Y; Nonaka I Acta Neuropathol; 1993; 85(3):280-4. PubMed ID: 8384773 [TBL] [Abstract][Full Text] [Related]
12. Histochemical and molecular genetic study of MELAS and MERRF in Korean patients. Kim DS; Jung DS; Park KH; Kim IJ; Kim CM; Lee WH; Rho SK J Korean Med Sci; 2002 Feb; 17(1):103-12. PubMed ID: 11850598 [TBL] [Abstract][Full Text] [Related]
13. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Petruzzella V; Moraes CT; Sano MC; Bonilla E; DiMauro S; Schon EA Hum Mol Genet; 1994 Mar; 3(3):449-54. PubMed ID: 7912129 [TBL] [Abstract][Full Text] [Related]
14. Patients with MELAS with negative myopathology for characteristic ragged-red fibers. Lu Y; Deng J; Zhao Y; Zhang Z; Hong D; Yao S; Zhao D; Xie J; Fang H; Yuan Y; Wang Z J Neurol Sci; 2020 Jan; 408():116499. PubMed ID: 31726383 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation. Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA. Graf WD; Sumi SM; Copass MK; Ojemann LM; Longstreth WT; Shanske S; Lombes A; DiMauro S Ann Neurol; 1993 Jun; 33(6):640-5. PubMed ID: 8388680 [TBL] [Abstract][Full Text] [Related]
17. Study of mitochondrial DNA depletion in muscle by single-fiber polymerase chain reaction. Sciacco M; Gasparo-Rippa P; Vu TH; Tanji K; Shanske S; Mendell JR; Schon EA; DiMauro S; Bonilla E Muscle Nerve; 1998 Nov; 21(11):1374-81. PubMed ID: 9771659 [TBL] [Abstract][Full Text] [Related]
18. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. James AM; Wei YH; Pang CY; Murphy MP Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):401-7. PubMed ID: 8809026 [TBL] [Abstract][Full Text] [Related]
19. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Betts J; Jaros E; Perry RH; Schaefer AM; Taylor RW; Abdel-All Z; Lightowlers RN; Turnbull DM Neuropathol Appl Neurobiol; 2006 Aug; 32(4):359-73. PubMed ID: 16866982 [TBL] [Abstract][Full Text] [Related]
20. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes). Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]